-
The Role of Flexible Cysto-Nephroscope in Enhancing Stone-Free Rates of Percutaneous Nephrolithotomy: A Global Survey
Sep 9, 2025, 16:22 PM -
DARWIN EU® Characterizing Clinically Recognized Hypertrophic Cardiomyopathy in Six European Countries: A Descriptive Analysis Using Real-World Data
Sep 9, 2025, 16:22 PM -
COVID-19's Effects on Mental Health Services: The Effectiveness of Telepsychiatry and Challenges in Substance Use Disorders in the United States
Sep 9, 2025, 16:22 PM -
Patient Preferences and Tradeoffs for Therapy-Related Factors of Antivascular Endothelial Growth Factor Agents: A Discrete Choice Experiment
Sep 9, 2025, 16:22 PM -
Spinal Muscular Atrophy Treatments in France: What Are the Organizational Economic and Environmental Impacts of Oral and Intrathecal Administrations
Sep 9, 2025, 16:22 PM -
A Cost-Effectiveness Analysis of the Switch to 20-Valent Pneumococcal Conjugate Vaccine From Lower-Valent Vaccines in the French Pediatric Population
Sep 9, 2025, 16:22 PM -
Exploring Methodologies for Defining and Modeling Cure in Melanoma: Impacts on Estimating Cure Metrics
Sep 9, 2025, 16:22 PM -
Harmonization or Hindrance? A Strategic Analysis of Divergent National Requirements Under the EU Joint Clinical Assessment
Sep 9, 2025, 16:22 PM -
Targeted Review of mITT vs. ITT Data in CAR-T Submissions
Sep 9, 2025, 16:22 PM -
Environmental Sustainability in HTA: To What Extent Are HTA Bodies Considering Environmental Considerations in Their Decision Making?
Sep 9, 2025, 16:22 PM -
Utilization of Glucagon-Like Peptide-1 Receptor Agonists in the Irish Healthcare System
Sep 9, 2025, 16:22 PM -
Analysis of Clinical and Economic Evidence Focused on RWE in Medicare Drug Price Negotiations: Sacubitril/Valsartan, Rivaroxaban, and Apixaban
Sep 9, 2025, 16:22 PM -
Organizational Support in Adopting New Treatments for Generalized Myasthenia Gravis
Sep 9, 2025, 16:22 PM -
Treatment Effect Extrapolation Assumptions in NICE Highly Specialized Technology Appraisals
Sep 9, 2025, 16:22 PM -
Economic Valuation of Premature COVID-19 Mortality in Kuwait: A Comparative Analysis of Three Methodological Approaches
Sep 9, 2025, 16:22 PM -
Digital Therapeutics in Europe: A Structured Review of Reimbursement and Access Pathways
Sep 9, 2025, 16:22 PM -
What Did Time Reveal Evaluating the Accuracy of Parametric Model Predictions Against Long-Term Observed Data for Larotrectinib?
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of Subcutaneous Ocrelizumab for Relapsing Multiple Sclerosis in Italy: A Hospital Perspective
Sep 9, 2025, 16:22 PM -
Healthcare Resource Utilization for Patients With Transthyretin Amyloid Cardiomyopathy: A Real-World Study in Europe, Canada, and Japan
Sep 9, 2025, 16:22 PM -
Characteristics of Patients Treated With Biologic Agents for Moderate-to-Severe Atopic Dermatitis in Poland
Sep 9, 2025, 16:22 PM